Approvals/TGA/CRESEMBA isavuconazole (as isavuconazonium sulfate) 100 mg capsule blister pack

Approved

STANDARD

CRESEMBA isavuconazole (as isavuconazonium sulfate) 100 mg capsule blister pack

Pfizer Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: bbadb51f5b9749de
Product Name: CRESEMBA isavuconazole (as isavuconazonium sulfate) 100 mg capsule blister pack
Artg Id: 305452
Artg Name: CRESEMBA isavuconazole (as isavuconazonium sulfate) 100 mg capsule blister pack
Sponsor: Pfizer Australia Pty Ltd
Company Detail Path: /organization/pfizer-australia-pty-ltd
Artg Date: 2019-05-17
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2019-CMI-02410-1
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2019-PI-01539-1

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

bbadb51f5b9749de

Type

Standard